In times of uncertainty, a dose of positive news reminds us that making progress through difficult situations is possible — our Children’s Hospital of Philadelphia research community does it every day!
Category Archive: Cancer
Although October is just ending, we’re already looking ahead to the New Year in this week’s installment of In the News.
Every space flight mission requires a carefully planned trajectory, and similarly the national Cancer Moonshot initiative needed a scientific roadmap to reach its ambitions of accelerating the prevention, diagnosis, and treatment of cancer to make a decade of progress in the next five years.
Welcome back to another weekly roundup of research news from the Children’s Hospital of Philadelphia! Exciting and important pediatric research spans everything from conditions that are common and treatable, such as ear infections, to others more rare and deadly, such as cancer.
Many scientific endeavors take place quietly behind laboratory walls, but this week’s In the News items are worth shouting about.
Welcome back to our weekly roundup of pediatric research news from The Children’s Hospital of Philadelphia. This week, as many students head back to school, the American Academy of Pediatrics (AAP) is strengthening its advocacy to protect individual and public health by calling for an end to nonmedical exemptions from school vaccine requirements.
Whether children are under the steady hand of surgeon and anesthesiologist, or medical and research trainees are under the guidance of an experienced mentor, knowledge makes all the difference. This much is clear from the top stories in our weekly roundup of research news at The Children’s Hospital of Philadelphia.
A study from researchers at The Children’s Hospital of Philadelphia may add new lines to the textbook description of how cancer cells divide uncontrollably and develop into tumors.
Researchers at The Children’s Hospital of Philadelphia reported their latest results from their studies of an investigational personalized cell therapy for a highly aggressive form of cancer, acute lymphoblastic leukemia (ALL).
Pediatric oncology researchers have narrowed down a culprit in an aggressive form of the childhood cancer neuroblastoma that makes the disease progress once tumors form.